Pathway
Defective homologous recombination repair (HRR) due to PALB2 loss of function
Biallelic loss-of-function mutations in PALB2 results in Fanconi anemia subtype N (FA-N), which is phenotypically very similar to Fanconi anemia subtype D1, caused by biallelic loss-of-function of BRCA2. FA-D1 and FA-N are characterized by developmental abnormalities, bone marrow failure and childhood cancer susceptibility, especially childhood solid tumors, such as Wilms tumor and medulloblastoma. Monoallelic PALB2 loss-of-function is an underlying cause of hereditary breast cancer in particular, but inactivating PALB2 mutations are also to a lesser extent found in some other cancer types, including pancreatic cancer. Germline PALB2 mutations are somewhat less frequent than those occurring in BRCA1 and BRCA2, but cause a comparably high risk of developing breast cancer. Therefore, PALB2 is a high-risk breast cancer predisposing gene.
Continue reading
PALB2 interacts with both BRCA1 and BRCA2, and serves as a bridge that connects BRCA2 with BRCA1 at sites of DNA double-strand break repair (DSBR). PALB2 also interacts directly with DNA and takes part in the regulation of RAD51-mediated homologous recombination. PALB2 loss-of-function mutations can affect its interaction with BRCA1 when they affect the N-terminal coiled-coil domain that is necessary for BRCA1 binding. Mutations in the coiled-coil domain can also affect PALB2 self-interaction, recruitment to double-strand break sites, homologous recombination repair and RAD51 foci formation. PALB2 missense mutants that do not bind to BRCA1 can still be recruited to DSBR sites, probably through interaction with other proteins involved in DSBR, but they are unable to restore efficient gene conversion in PALB2-deficient cells and they render cells hypersensitive to the DNA damaging agent mitomycin C, with some variants also presenting sensitivity to PARP inhibitors.
Mutations evaluated so far in the central region of PALB2, which contains the ChAM motif and the MRG15-binding region, have shown no functional impact on the protein.
Mutations affecting the C-terminal WD40 domain of PALB2 impair its ability to interact with BRCA2, RAD51 and/or RAD51C. In addition, disruption of the WD40 domain can lead to the exposure of a nuclear export signal (NES), leading to cytoplasmic translocation of PALB2. Mutations affecting the C-terminal domain of PALB2 are more frequent than mutations that affect the N-terminus and have been observed, as germline mutations, in familial breast cancer and in Fanconi anemia, but somatic mutations also occur in sporadic cancers. Cells that express PALB2 mutants defective in BRCA2, RAD51 and/or RAD51C binding show reduced ability to perform DSBR via homologous recombination repair, form fewer RAD51 foci at DSBR sites, and are sensitive to DNA crosslinking agents such as mitomycin C.
For review, please refer to Tischkowitz and Xia 2010, Pauty et al. 2014, Park et al. 2014, Nepomuceno et al. 2017, Ducy et al. 2019, Wu et al. 2020, Nepomuceno et al. 2021.
What the reference databases state
Statements
25 statements
25 statements · 1 reference database · Subject: Defective homologous recombination repair (HRR) due to PALB2 loss of function · Sources: Reactome
- ATM participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- BARD1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- BLM participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- BRCA1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- BRCA2 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- BRIP1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- DNA2 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- EXO1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- KAT5 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- MRE11 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- NBN participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- PALB2 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
Show the remaining 13
- RAD50 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RAD51 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RAD51AP1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RAD51B participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RAD51C participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RAD51D participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RBBP8 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RMI1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- RMI2 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- SEM1 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- TOP3A participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- WRN participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only
- XRCC2 participates in Defective homologous recombination repair (HRR) due to PALB2 loss of functionProteinReactome R-HSA-9701193Inferred only